Get the Stockscreener App
4.035
5.94%
-0.255
Pre-market:
4.59
0.555
+13.75%
Sera Prognostics Inc stock is traded at $4.035, with a volume of 35,171.
It is down -5.94% in the last 24 hours and down -5.50% over the past month.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
See More
Previous Close:
$4.29
Open:
$4.23
24h Volume:
35,171
Relative Volume:
0.28
Market Cap:
$141.32M
Revenue:
$306.00K
Net Income/Loss:
$-36.24M
P/E Ratio:
-3.4784
EPS:
-1.16
Net Cash Flow:
$-27.32M
1W Performance:
-2.77%
1M Performance:
-5.50%
6M Performance:
-47.32%
1Y Performance:
-55.90%
1-Day Range:
$4.03
$4.24
1-Week Range:
$3.91
$4.35
52-Week Range:
$3.84
$12.36
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
4.035 | 141.32M | 306.00K | -36.24M | -27.32M | -1.16 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Don't Ignore The Insider Selling In Sera Prognostics - Simply Wall St
Sera Prognostics (SERA) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Sera Prognostics Sets Key Earnings Date: What to Expect From Q4 and FY2024 Results - StockTitan
Sera Prognostics CFO sells shares for $19,850 By Investing.com - Investing.com UK
Sera prognostics CIO sells $16,115 in company stock - Investing.com
Sera prognostics CEO sells $122,454 in stock - Investing.com
Sera Prognostics CFO sells shares for $19,850 - Investing.com India
SERA Prognostics Executives Sell Shares for Tax Obligations and Under Trading Plan - TradingView
Rhumbline Advisers Purchases 3,468 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics CFO sells shares worth $2,246 By Investing.com - Investing.com South Africa
Sera prognostics chief scientific officer sells $8,503 in stock By Investing.com - Investing.com South Africa
Sera Prognostics chief data officer sells $5,566 in stock By Investing.com - Investing.com South Africa
Sera prognostics CIO sells $13,524 in stock By Investing.com - Investing.com South Africa
Sera prognostics director Mirza Mansoor Raza sells $411 in stock By Investing.com - Investing.com Canada
Sera prognostics general counsel sells $9,505 in stock - Investing.com
Sera prognostics director Mirza Mansoor Raza sells $411 in stock - Investing.com India
Sera prognostics CIO sells $13,524 in stock - Investing.com India
Sera Prognostics chief data officer sells $5,566 in stock - Investing.com
The Femtech leaders transforming women’s health - Management-Issues
Sera Prognostics at TD Cowen: Innovative Approaches to Preterm Birth - Investing.com
Sera Prognostics at TD Cowen: Innovative Approaches to Preterm Birth By Investing.com - Investing.com UK
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates - Yahoo Finance
Preeclampsia Therapeutic Market Redefining Connectivity and Efficiency in the Digital Era - ExpressVartha
Sera Prognostics (NASDAQ:SERA) Stock Price Down 0.5%Here's What Happened - MarketBeat
Grail (NASDAQ:GRAL) vs. Sera Prognostics (NASDAQ:SERA) Head-To-Head Review - Defense World
Sotera Health Company (SHC) Meets Q4 Earnings Estimates - Yahoo Finance
US Penny Stocks To Watch In February 2025 - Simply Wall St
Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference - Longview News-Journal
Can Sera Prognostics Revolutionize Pregnancy Care? CEO Reveals Strategy at Major Healthcare Conference - StockTitan
Sera Prognostics CEO sells $64,463 in stock - MSN
Sera Prognostics CIO Harrison Gardner sells stock worth $15,450 - MSN
Sera Prognostics chief scientific officer sells shares for $27,090 - MSN
Sera Prognostics chief scientific officer sells shares for $27,090 By Investing.com - Investing.com Nigeria
Sera Prognostics CIO Harrison Gardner sells $2,199 in stock - MSN
Sera Prognostics CFO sells $27,090 in stock By Investing.com - Investing.com Canada
Sera prognostics chief data officer Paul Kearney sells $24,466 in stock - Investing.com Nigeria
Sera Prognostics CIO Harrison Gardner sells stock worth $15,450 By Investing.com - Investing.com South Africa
Sera prognostics chief data officer Paul Kearney sells $24,466 in stock By Investing.com - Investing.com South Africa
Sera Prognostics CFO sells $27,090 in stock - Investing.com
SERA Prognostics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView
Sera Prognostics CEO sells $64,463 in stock By Investing.com - Investing.com Canada
Sera Prognostics announces proposed public offering - MSN
Sera Prognostics stock hits 52-week low at $3.84 amid market challenges - MSN
Sera Prognostics CIO Harrison Gardner sells $2,199 in stock By Investing.com - Investing.com Canada
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):